Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Harvard Business School
Cerilliant
US Army
Boehringer Ingelheim
Federal Trade Commission
Baxter
Julphar
Novartis

Generated: February 21, 2018

DrugPatentWatch Database Preview

Reserpine; trichlormethiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for reserpine; trichlormethiazide and what is the scope of reserpine; trichlormethiazide freedom to operate?

Reserpine; trichlormethiazide
is the generic ingredient in four branded drugs marketed by Sanofi Aventis Us, Schering, and Watson Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for reserpine; trichlormethiazide.
Summary for reserpine; trichlormethiazide

US Patents and Regulatory Information for reserpine; trichlormethiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TRICHLORMETHIAZIDE W/ RESERPINE reserpine; trichlormethiazide TABLET;ORAL 085248-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering NAQUIVAL reserpine; trichlormethiazide TABLET;ORAL 012265-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us METATENSIN #4 reserpine; trichlormethiazide TABLET;ORAL 012972-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us METATENSIN #2 reserpine; trichlormethiazide TABLET;ORAL 012972-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Covington
Teva
UBS
AstraZeneca
Daiichi Sankyo
Moodys
Fish and Richardson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot